Acorda Therapeutics Inc. (ACOR)
NASDAQ: ACOR
· Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM
Acorda Therapeutics Revenue
Acorda Therapeutics reported an annual revenue of $117.63M, reflecting a -0.79% growth. For the quarter ending March 31, 2024, Acorda Therapeutics generated $20.29M in revenue.
Revenue (ttm)
$117.63M
Revenue Growth
-0.79%
Price / Sales Ratio
0.16
Revenue / Employee
$1.15M
Employees
102
Market Cap
821.03K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 117.63M | -0.79% |
| Dec 31, 2022 | 118.57M | -8.14% |
| Dec 31, 2021 | 129.07M | -15.62% |
| Dec 31, 2020 | 152.97M | n/a |